Cerebrospinal fluid biomarkers are proteins and molecules measured in spinal fluid to detect neurological conditions like Alzheimer's and multiple sclerosis. They aid early diagnosis, track disease progression, and guide treatment decisions. Patients with cognitive decline or suspected brain disorders benefit most, gaining access to timely, personalized care.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends